News | Patient Engagement | September 15, 2015

Michigan ‘See You in 7’ Program Helps Reduce Heart Failure Readmissions

ACC program encourages early follow-up after hospital discharge

Michigan, See You in 7, heart failure, readmissions, ACC

September 15, 2015 — Michigan hospitals participating in the American College of Cardiology’s “See You in 7” program demonstrated important reductions in 30-day readmission rates for Medicare heart failure patients compared to non-participating hospitals. The improvements came despite only modest increases in seven-day follow-up appointments, according to a study in JACC: Heart Failure.

“See You in 7” is part of the ACC’s Hospital-to-Home initiative, a national quality improvement program aimed at reducing heart disease-related hospital readmissions and improving the transition from hospital to home. “See You in 7” challenges hospitals to ensure all discharged heart failure and heart attack patients have a follow-up appointment scheduled within seven days of hospital discharge.

“Readmissions of heart failure patients remain one of the most important clinical challenges today,” said JACC: Heart Failure Editor-in-Chief Christopher O’Connor, M.D., FACC. “Transitional care programs may represent our best opportunity to reduce the burden on patients and health systems.”

Researchers looked at the seven-day follow-up and 30-day readmission rates for Medicare heart failure patients at 10 hospitals in the Southeast Michigan “See You in 7” Collaborative and compared them to non-participating hospitals both before joining the “See You in 7” program and after one year of participation.

The one-year program included three phases: implementation, intervention and evaluation periods. During implementation, hospitals selected at least one metric from the “See You in 7” toolkit to focus their efforts and measure progress.

Metrics included:

  • Identify heart failure patients prior to discharge;
  • Schedule and document a follow-up visit with a cardiology or primary care doctor within seven days of discharge;
  • Provide patients with documentation of scheduled follow-up;
  • Identify and address barriers to keeping appointment;
  • Ensure patients arrive at scheduled follow-up appointment; and
  • Make discharge summary available to follow-up healthcare providers.

At the end of the program, both participating and non-participating hospitals’ seven-day follow-up rates increased but remained low—31 to 34 percent for participating hospitals and 30 to 32 percent for non-participating hospitals. However, adjusted 30-day readmission rates decreased substantially in participating hospitals compared to non-participating hospitals. Participating hospitals saw readmissions decrease 2.6 percent, while non-participating hospitals saw a 0.6 percent reduction.

“Our study clearly shows there are challenges in coordinating early follow-up care, since increases in seven-day post-discharge follow-up were modest. However, despite this, hospitals in the program stepped up to address deficiencies in post-hospital care and reduce 30-day readmissions,” said Sandra Marie Oliver-McNeil, DNP, ACNP-BC, a study author and assistant professor of nursing at Wayne State University. “Through collaboratively addressing the ‘See You in 7’ goals, hospitals participating in this program learned from each other when helping their patients transition from hospital to home, and they should serve as an encouraging example for other regional hospitals to share best practices.”

According to the study, participating hospitals designated a staff member to document successful seven-day follow-up visits or investigate why the visits did not take place, leading to more engaged patients and caregivers and giving both sides a better understanding of barriers to care. These efforts may have led to the reduced 30-day readmission rates.

Medicare payments per patient also decreased in participating hospitals. Combined payments for inpatient and 30 days of post-discharge care decreased by $182 in participating hospitals and $63 in non-participating hospitals.  

For more information: www.acc.org

Related Content

First-in-Man RenalGuard Studies Show Promise for Heart Failure Patients
News | Heart Failure| January 02, 2018
RenalGuard Solutions Inc. reported positive results from a first-in-man feasibility study focusing on a novel use of...
ACC Issues New Guidance to Optimize Heart Failure Treatment
News | Heart Failure| December 22, 2017
December 22, 2017 — To help streamline treatment of patients with...
Coffee Associated With Reduced Risk of Heart Failure, Stroke. AHA 2017. #AHA2017
News | Heart Failure| November 25, 2017
November 25, 2017 — Drinking coffee may be associated with a decreased risk of developing heart failure or having str
Heart failure associated with methamphetamine (meth) use has risen dramatically in recent years among U.S. veterans, according to preliminary research presented at the 2017 American Heart Association (AHA) Scientific Sessions.
News | Heart Failure| November 25, 2017
November 25, 2017 — Heart failure associated with methamphetamine (meth) use has risen dramatically in recent years a
The Corvia intra-atrial shunt to treat diastolic heart failure.

The Corvia intra-atrial shunt to treat diastolic heart failure.

Feature | Heart Failure| November 25, 2017
November 25, 2017 – Results presented at the 2017 American Heart Association (AHA) Scientific Sessions and published
Surgery Could Reduce Frailty in Adults With Heart Failure
News | Heart Failure| November 17, 2017
November 17, 2017 — Common practice, and recently published research, shows that the risk of complications with surge
News | Heart Failure| November 13, 2017
November 10, 2017 — Moderna Therapeutics announced a new license and collaboration with AstraZeneca to co-develop and
Scientists Reverse Advanced Heart Failure in Mouse Model
News | Heart Failure| October 30, 2017
October 30, 2017 — Researchers have discovered a previously unrecognized healing capacity of the heart.
Trial Data Shows Positive Predictive Results for Boston Scientific HeartLogic Heart Failure Diagnostic
News | Heart Failure| October 20, 2017
October 20, 2017 — Boston Scientific announced new data from the Multisensor Chronic Evaluation in Ambulatory Heart F
The Respicardia Remede System is a pacemaker-like device designed to improve cardiovascular health by restoring natural breathing during sleep in patients with Central sleep apnea.
Technology | Heart Failure| October 18, 2017
October 18, 2017 — The U.S.
Overlay Init